Nanomedicine News RSS Feed - Nanomedicine

Nanoparticles Target Hard-to-Reach Cancers Without Causing Damaging Side Effects

Nanoparticles Target Hard-to-Reach Cancers Without Causing Damaging Side Effects

Scientists at Brunel University London have found a way of targeting hard-to-reach cancers and degenerative diseases using nanoparticles, but without causing the damaging side effects the treatment normally brings. [More]
Nanomimics of Host Cell Membranes can Trick Malaria Parasites

Nanomimics of Host Cell Membranes can Trick Malaria Parasites

Malaria parasites invade human red blood cells, they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano. [More]
Hybrid Chemical/Genetic Therapy Helps Blind Mice Regain Light Sensitivity

Hybrid Chemical/Genetic Therapy Helps Blind Mice Regain Light Sensitivity

A new genetic therapy not only helped blind mice regain enough light sensitivity to distinguish flashing from non-flashing lights, but also restored light response to the retinas of dogs, setting the stage for future clinical trials of the therapy in humans. [More]
Lab-on-a-disc Device for Inexpensive Cancer Diagnosis

Lab-on-a-disc Device for Inexpensive Cancer Diagnosis

It’s the one word no one wants to hear escape from their doctor’s lips. But each year, 12.7 million people around the world do. [More]
Pioneering Research Contributions in Nanomedicine Wins Chancellor’s Innovation Award

Pioneering Research Contributions in Nanomedicine Wins Chancellor’s Innovation Award

Samuel A. Wickline, MD, has been chosen to receive the Chancellor’s Award for Innovation and Entrepreneurship at Washington University in St. Louis. [More]
Jena Scientists Successfully Produce Highly Specific Nanoparticles

Jena Scientists Successfully Produce Highly Specific Nanoparticles

Jena scientists have been successful in producing highly specific nanoparticles. Depending on the bound dye the particles are guided to the liver or to the kidney and deliver their payload of active ingredients directly to the targeted tissue. [More]
Nanotube Device Could Potentially Replace Damaged Retina

Nanotube Device Could Potentially Replace Damaged Retina

The aging process affects everything from cardiovascular function to memory to sexuality. Most worrisome for many, however, is the potential loss of eyesight due to retinal degeneration. [More]
Global Industry Analysis Report on Nanomedicine Market

Global Industry Analysis Report on Nanomedicine Market

Transparency Market Research has announced the release of a report titled “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” [More]
Tekmira Licenses Lipid Nanoparticle Technology for Dicerna's PH1 Development Program

Tekmira Licenses Lipid Nanoparticle Technology for Dicerna's PH1 Development Program

Tekmira Pharmaceuticals Corporation a leading developer of RNA interference (RNAi) therapeutics, today announces a licensing and collaboration agreement with Dicerna Pharmaceuticals, Inc. Tekmira has licensed its proprietary lipid nanoparticle (LNP) delivery technology for exclusive use in Dicerna's primary hyperoxaluria type 1 (PH1) development program. [More]
Stem Cell Therapy and Nanotechnology Drive Global Regenerative Medicine Market

Stem Cell Therapy and Nanotechnology Drive Global Regenerative Medicine Market

Research and Markets has announced the addition of the "Global Regenerative Medicines Market 2014-2020 - Technology, Application and Geography Analysis of the $67 Billion Industry" report to their offering. [More]